コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 continent to cause epidemics of highly fatal hemorrhagic fever.
2 of which are filoviruses) that cause severe hemorrhagic fever.
3 rotective vaccine candidate against Bolivian hemorrhagic fever.
4 ease that sometimes leads to encephalitis or hemorrhagic fever.
5 us (MACV) is the causative agent of Bolivian hemorrhagic fever.
6 ment of vaccines or therapeutics for Marburg hemorrhagic fever.
7 rus (JUNV), the causative agent of Argentine hemorrhagic fever.
8 causative agents of dengue fever and dengue hemorrhagic fever.
9 hagic fever virus (SHFV) causes lethal viral hemorrhagic fever.
10 is an emerging zoonotic pathogen that causes hemorrhagic fever.
11 Ebolaviruses cause severe hemorrhagic fever.
12 om a rodent to humans and can lead to lethal hemorrhagic fever.
13 lavirus is an enveloped virus causing severe hemorrhagic fever.
14 uses responsible for dengue fever and dengue hemorrhagic fever.
15 ackground determines susceptibility to Ebola hemorrhagic fever.
16 reduced mortality in a monkey model of Ebola hemorrhagic fever.
17 the majority of severe cases, termed dengue hemorrhagic fever.
18 cantly with the demographic burden of dengue hemorrhagic fever.
19 t Africa and responsible for severe cases of hemorrhagic fever.
20 viral clearance and defervescence in dengue hemorrhagic fever.
21 Health Organization classification of dengue hemorrhagic fever.
22 uses that cause sporadic outbreaks of severe hemorrhagic fever.
23 n virus is used to protect against Argentine hemorrhagic fever.
24 mptoms, such as hepatitis, encephalitis, and hemorrhagic fever.
25 oviruses, are the causative agents of severe hemorrhagic fever.
26 potential therapeutic agents to treat Lassa hemorrhagic fever.
27 each year, many of which develop into fatal hemorrhagic fever.
28 Filoviruses (Ebola and Marburg) cause severe hemorrhagic fever.
29 ated with a cluster of human cases of severe hemorrhagic fever.
30 surrogate small animal model for arenavirus hemorrhagic fevers.
31 agnostic replacement for the ELISA for viral hemorrhagic fevers.
32 zation clinical-investigation form for viral hemorrhagic fevers.
33 ruses, arenaviruses, and bunyaviruses, cause hemorrhagic fevers.
34 s in improving disease outcomes during viral hemorrhagic fevers.
35 ted intravascular coagulation in one or more hemorrhagic fevers.
36 vaccines against Lassa and other arenaviral hemorrhagic fevers.
37 tly asymptomatic infections to severe, viral hemorrhagic fevers.
38 may be useful in the treatment of arenavirus hemorrhagic fevers.
39 t of effective therapies to treat arenaviral hemorrhagic fevers.
40 anslation apparatus.IMPORTANCE Crimean-Congo hemorrhagic fever, a highly contagious viral disease end
41 s (JUNV) is the causative agent of Argentine hemorrhagic fever (AHF), a potentially deadly disease en
42 etiological agent responsible for Argentine hemorrhagic fever (AHF), activates an early innate immun
43 unin virus, the causative agent of Argentine hemorrhagic fever (AHF), is an arenavirus identified as
54 A/MDL-1, a C-type lectin critical for dengue hemorrhagic fever and Japanese encephalitis virus infect
56 elop severe manifestations, including dengue hemorrhagic fever and shock syndrome, resulting in ~25,0
58 lular and molecular mechanisms of arenaviral hemorrhagic fever and suggests potential strategies for
59 e systemic human infections characterized by hemorrhagic fever and/or neurological manifestations, co
60 Thus, IFN-I may play a prominent role in hemorrhagic fevers and other acute virus infections asso
62 the causative agent of dengue fever, dengue hemorrhagic fever, and dengue shock syndrome and is ende
63 ely high fatality rates in Ebola and Marburg hemorrhagic fevers, and asymptomatic infection predomina
64 in South America as the cause of often fatal hemorrhagic fevers, and, although Demogines et al. could
66 disease severity and virulence in arenavirus hemorrhagic fever are largely unknown, particularly rega
69 GP1 glycoprotein from Junin virus (JUNV), a hemorrhagic fever arenavirus endemic in central Argentin
77 dies of the GPC envelope glycoprotein of the hemorrhagic fever arenaviruses, we have shown that GPC i
79 (MACV) is the etiological agent of Bolivian hemorrhagic fever (BHF), a reemerging and neglected trop
81 rotect at-risk individuals against Argentine hemorrhagic fever, but it has not been licensed in the U
83 he focus on vaccine development against this hemorrhagic fever-causing pathogen, and as a consequence
84 on mechanisms between arenaviruses and other hemorrhagic fever-causing viruses, such as Ebola, Marbur
85 ol ticks carrying the emerging Crimean-Congo hemorrhagic fever (CCHF) in Turkey the government is int
91 uding 15 viruses (chikungunya, Crimean-Congo hemorrhagic fever [CCHF] virus, dengue, Ebola virus, Bun
92 plete resistance to lethal disease to severe hemorrhagic fever characterized by prolonged coagulation
93 c fever (CCHF) is a widely distributed viral hemorrhagic fever characterized by rapid onset of flu-li
95 ed data from the Sierra Leone National Viral Hemorrhagic Fever Database, contact tracing records, Ken
96 ng to clinical dengue classification; dengue hemorrhagic fever/dengue shock syndrome severity; durati
99 r decades, the gold-standard immunoassay for hemorrhagic fever detection has been the enzyme-linked i
100 enrollment in patients who developed dengue hemorrhagic fever (DHF) (n = 11), compared with the non-
101 ut, in severe cases, life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS)
102 ter vascular fluid barrier functions, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
103 er (DF) and its severe complications, dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
104 se, and it can cause life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
105 -B44 supertype was protective against dengue hemorrhagic fever (DHF) in secondary infections (odds ra
106 NNIg) is the greatest risk factor for dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS).
107 develop the life-threatening diseases dengue hemorrhagic fever (DHF) or dengue shock syndrome (DSS).
108 V-1-4) that causes Dengue fever (DF), Dengue hemorrhagic Fever (DHF) or Dengue shock syndrome (DSS).
110 range of symptoms: dengue fever (DF), dengue hemorrhagic fever (DHF), and dengue shock syndrome (DSS)
111 ry dengue virus (DENV) infections and dengue hemorrhagic fever (DHF), the majority of secondary infec
114 enting as dengue fever (DF; mild) and dengue hemorrhagic fever (DHF; severe) and subjects with a nons
115 ral members of the Arenaviridae family cause hemorrhagic fever disease in humans and pose serious pub
116 naviruses, chiefly Lassa virus (LASV), cause hemorrhagic fever disease in humans and pose serious pub
119 athogens, since several of them cause severe hemorrhagic fever disease that is associated with high m
120 Machupo viruses, can cause severe and deadly hemorrhagic fever diseases in humans, and there are limi
123 ssa fever virus, can cause severe and lethal hemorrhagic fever diseases with high mortality and morbi
128 zed by "abortion storms" in ruminants and by hemorrhagic fever, encephalitis, and blindness in humans
129 by a high rate of abortion in ruminants and hemorrhagic fever, encephalitis, or blindness in humans.
130 ses a high rate of abortion in ruminants and hemorrhagic fever, encephalitis, or blindness in humans.
131 veloped filamentous RNA virus causing severe hemorrhagic fever, enters cells by macropinocytosis and
132 Marburg virus (MARV) infection is a lethal hemorrhagic fever for which no licensed vaccines or ther
134 unin virus, the causative agent of Argentine hemorrhagic fever, for high-throughput screening (HTS).
135 infrastructure for research regarding viral hemorrhagic fever, has received and cared for patients w
136 es for managing patients infected with viral hemorrhagic fevers have evolved as new information has b
137 naviruses, chiefly Lassa virus (LASV), cause hemorrhagic fever (HF) disease in humans and pose a grea
138 naviruses, chiefly Lassa virus (LASV), cause hemorrhagic fever (HF) disease in humans and pose a sign
139 aviruses include several causative agents of hemorrhagic fever (HF) disease in humans that are associ
142 es a severe and almost uniformly fatal viral hemorrhagic fever in Asian macaques but is thought to be
143 ) has caused highly fatal outbreaks of viral hemorrhagic fever in captive Asian macaque colonies.
144 rus, have caused sporadic outbreaks of viral hemorrhagic fever in captive macaque monkeys since the 1
145 y discovered Phlebovirus causing an emerging hemorrhagic fever in East Asia, with reported case fatal
149 a highly pathogenic virus that causes severe hemorrhagic fever in humans and is responsible for epide
151 us, are zoonotic pathogens that cause severe hemorrhagic fever in humans and nonhuman primates (NHPs)
152 avirus (SEBOV), cause severe and often fatal hemorrhagic fever in humans and nonhuman primates (NHPs)
153 s (MARV) and Ebola virus (EBOV) cause severe hemorrhagic fever in humans and nonhuman primates (NHPs)
154 ongs to the virus family Filoviridae, causes hemorrhagic fever in humans and nonhuman primates that i
157 highly pathogenic viruses that cause severe hemorrhagic fever in humans and other mammals with high
159 (BDBV) is the etiological agent of a severe hemorrhagic fever in humans with a case-fatality rate ra
160 us (EBOV) is the causative agent of a severe hemorrhagic fever in humans with reported case fatality
161 la virus causes sporadic outbreaks of lethal hemorrhagic fever in humans, but there is no currently a
168 rging zoonotic virus that causes often-fatal hemorrhagic fever in infected humans for which preventat
169 emorrhagic fever virus (SHFV) causes a fatal hemorrhagic fever in macaques but an asymptomatic, persi
170 layed a role in previous outbreaks of simian hemorrhagic fever in macaques, as has long been suspecte
172 (EBOV) causes a highly infectious and lethal hemorrhagic fever in primates with high fatality rates d
173 irus (EBOV) is the causative agent of severe hemorrhagic fever in primates, with human case fatality
174 us is responsible for outbreaks of Argentine hemorrhagic fever in South America, where 5 million peop
176 ecently identified from a patient with acute hemorrhagic fever in the Bas-Congo province of the Democ
177 The massive outbreak of highly lethal Ebola hemorrhagic fever in West Africa illustrates the urgent
178 Infections by these viruses can cause severe hemorrhagic fevers in humans and nonhuman primates with
185 are responsible for severe life-threatening hemorrhagic fevers in western Africa and South America.
186 the clinical hallmarks observed with Marburg hemorrhagic fever, including lymphopenia, thrombocytopen
187 opment of antiviral strategies against viral hemorrhagic fevers, including AHF, is one of the top pri
188 ment of antiviral strategies to combat viral hemorrhagic fevers, including Bolivian hemorrhagic fever
191 able for clinical evaluation.IMPORTANCE EBOV hemorrhagic fever is one of the most lethal viral infect
192 viral hemorrhagic fevers, including Bolivian hemorrhagic fever, is one of the top priorities of the I
193 unin virus, the causative agent of Argentine hemorrhagic fever, it is licensed for use only in areas
195 virus (LASV) is the causative agent of Lassa hemorrhagic fever (LF) in humans, a deadly disease endem
196 rus (PICV) is a BSL2 pathogen that can cause hemorrhagic fever-like symptoms in guinea pigs that rese
197 host cell surface receptor for all New World hemorrhagic fever mammarenaviruses-and mimics an importa
200 do not reproduce hallmark symptoms of Ebola hemorrhagic fever, neither delayed blood coagulation and
201 es, infected individuals can also experience hemorrhagic fever, neurological disorders, liver failure
204 ess annually, escalating to life-threatening hemorrhagic fever or shock syndrome in approximately 500
207 exceptions, vaccines for viruses that cause hemorrhagic fever remain unavailable or lack well-docume
208 al loads are characteristic of several viral hemorrhagic fevers, severe plasma leakage occurs at the
210 ual epidemics of virus-induced encephalitis, hemorrhagic fever\shock syndromes, and arthritis, respec
212 Ebola virus disease (EVD), a severe viral hemorrhagic fever syndrome caused by Ebola virus (EBOV)
215 s (e.g., Lassa and Junin) which cause severe hemorrhagic fever syndromes with high mortality rates.
216 onging to the family Filoviridae that causes hemorrhagic fever syndromes with high-mortality rates.
217 ations that minimize the incidence of dengue hemorrhagic fever, taking into account limited availabil
218 ers of the Filoviridae family, causes severe hemorrhagic fever that is highly lethal, with up to 90%
219 a viruses, related viruses that cause severe hemorrhagic fevers, the mechanism of nucleocapsid transp
220 ilitate the occurrence of more-severe dengue hemorrhagic fever through immune enhancement upon infect
221 data from non-human primate models of viral hemorrhagic fever to better understand the host transcri
226 d by clinical findings common to other viral hemorrhagic fevers (VHFs), including thrombocytopenia, l
234 s and, at least in the case of Crimean-Congo hemorrhagic fever virus (CCHFV), to cleave the Ub-like p
238 uses including TBEV, Louping ill virus, Omsk hemorrhagic fever virus (OHFV), Alkhurma virus (ALKV), K
242 infected crab-eating macaques, while simian hemorrhagic fever virus (SHFV) causes lethal viral hemor
245 then crab-eating macaques with either simian hemorrhagic fever virus (SHFV) or Kibale red colobus vir
251 of vOTUs originating from the Crimean-Congo hemorrhagic fever virus, Erve virus, and Nairobi sheep d
252 relatives of these viruses, including simian hemorrhagic fever virus, have caused sporadic outbreaks
253 llular entry of Ebola virus (EBOV), a deadly hemorrhagic fever virus, is mediated by the viral glycop
257 ic health importance, such as the category A hemorrhagic fever viruses Lassa virus, Junin virus, Mach
258 esponding to the challenges of confronting 2 hemorrhagic fever viruses will require continued investm
264 face.IMPORTANCE Although outbreaks of Korean hemorrhagic fever were first recognized during the Korea
265 bocytopenia is a common finding during viral hemorrhagic fever, which includes hemorrhagic fever with
266 oved vaccines and/or treatments for Bolivian hemorrhagic fever, which is a fatal human disease caused
267 one of several viruses that can cause viral hemorrhagic fever, which is characterized by uncontrolle
268 The virus from the Filoviridae family causes hemorrhagic fever, which rapidly progresses and in some
269 ortant human pathogen responsible for dengue hemorrhagic fever, whose global incidence has increased
271 of the genus Ebolavirus, result in a severe hemorrhagic fever with a fatal outcome in over 50% of hu
276 dent hosts but can lead to severe and lethal hemorrhagic fever with bleeding and multiorgan failure i
277 o includes Ebola virus (EBOV), causes lethal hemorrhagic fever with case fatality rates that have exc
279 nted negative-sense RNA virus causing severe hemorrhagic fever with high fatality rates in humans and
280 virus (EBOV) is an RNA virus that can cause hemorrhagic fever with high fatality rates, and there ar
281 Ebolavirus and Marburgvirus cause severe hemorrhagic fever with high mortality and are potential
284 nown to cause 2 distinct clinical syndromes: hemorrhagic fever with renal syndrome (HFRS) and hantavi
287 ct mammals, including humans, causing either hemorrhagic fever with renal syndrome (HFRS) or hantavir
289 causes of death are common in patients with hemorrhagic fever with renal syndrome (HFRS), which is c
298 dae family and can cause outbreaks of severe hemorrhagic fever, with high mortality rates in humans.
299 irus, a cousin of Ebola virus, causes severe hemorrhagic fever, with up to 90% lethality seen in rece
300 (EBOV) and related filoviruses cause severe hemorrhagic fever, with up to 90% lethality, and no trea
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。